ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 07:38 (2362 d 22:59 ago) – Posting: # 17945
Views: 9,210

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,664 registered users;
81 visitors (0 registered, 81 guests [including 6 identified bots]).
Forum time: 07:38 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5